Caseware UK (AP4) 2023.0.135 2023.0.135 2023-12-312023-12-3172022-07-01falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.No description of principal activity1truetruefalse 06041827 2022-07-01 2023-12-31 06041827 2023-12-31 06041827 2021-07-01 2022-06-30 06041827 2022-06-30 06041827 c:CompanySecretary1 2022-07-01 2023-12-31 06041827 c:Director1 2022-07-01 2023-12-31 06041827 c:Director2 2022-07-01 2023-12-31 06041827 c:Director2 2023-12-31 06041827 c:RegisteredOffice 2022-07-01 2023-12-31 06041827 d:PatentsTrademarksLicencesConcessionsSimilar 2022-07-01 2023-12-31 06041827 d:PatentsTrademarksLicencesConcessionsSimilar 2023-12-31 06041827 d:PatentsTrademarksLicencesConcessionsSimilar 2022-06-30 06041827 d:ComputerSoftware 2022-07-01 2023-12-31 06041827 d:ComputerSoftware 2023-12-31 06041827 d:ComputerSoftware 2022-06-30 06041827 d:CurrentFinancialInstruments 2023-12-31 06041827 d:CurrentFinancialInstruments 2022-06-30 06041827 d:Non-currentFinancialInstruments 2023-12-31 06041827 d:Non-currentFinancialInstruments 2022-06-30 06041827 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 06041827 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 06041827 d:Non-currentFinancialInstruments d:AfterOneYear 2023-12-31 06041827 d:Non-currentFinancialInstruments d:AfterOneYear 2022-06-30 06041827 d:ShareCapital 2023-12-31 06041827 d:ShareCapital 2022-06-30 06041827 d:RetainedEarningsAccumulatedLosses 2023-12-31 06041827 d:RetainedEarningsAccumulatedLosses 2022-06-30 06041827 c:FRS102 2022-07-01 2023-12-31 06041827 c:AuditExempt-NoAccountantsReport 2022-07-01 2023-12-31 06041827 c:FullAccounts 2022-07-01 2023-12-31 06041827 c:PrivateLimitedCompanyLtd 2022-07-01 2023-12-31 06041827 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2022-07-01 2023-12-31 06041827 d:ComputerSoftware d:OwnedIntangibleAssets 2022-07-01 2023-12-31 06041827 e:PoundSterling 2022-07-01 2023-12-31 iso4217:GBP xbrli:pure
Company registration number: 06041827







UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED
31 DECEMBER 2023


SHUTTLEWORTH MEDICAL LTD






































img5d34.png                        

 


SHUTTLEWORTH MEDICAL LTD
 


 
COMPANY INFORMATION


Directors
R S Singh 
M B Singh (appointed 18 August 2023)




Company secretary
M Miles



Registered number
06041827



Registered office
Blays Cottage
Blays Lane

Englefield Green

Egham

Surrey

TW20 0PB




Accountants
Menzies LLP
Chartered Accountants

1st Floor

Midas House

62 Goldsworth Road

Woking

Surrey

GU21 6LQ





 


SHUTTLEWORTH MEDICAL LTD
 



CONTENTS



Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 6


 


SHUTTLEWORTH MEDICAL LTD
REGISTERED NUMBER:06041827



STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2023

31 December
30 June
2023
2022
Note
£
£

Fixed assets
  

Intangible fixed assets
  
-
901

  
-
901

Current assets
  

Stocks
  
-
303,247

Debtors: amounts falling due within one year
 5 
133,756
560,099

Cash at bank and in hand
  
8,035
18,544

  
141,791
881,890

Creditors: amounts falling due within one year
 6 
(376)
(504,808)

Net current assets
  
 
 
141,415
 
 
377,082

Total assets less current liabilities
  
141,415
377,983

Creditors: amounts falling due after more than one year
 7 
-
(150,000)

  

Net assets
  
141,415
227,983


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
141,414
227,982

  
141,415
227,983


Page 1

 


SHUTTLEWORTH MEDICAL LTD
REGISTERED NUMBER:06041827


    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2023

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the period in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




................................................
R S Singh
Director

Date: 23 August 2024

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 


SHUTTLEWORTH MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

1.


General information

Shuttleworth Medical Limited is aprivate Company limited by shares incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of its registered office is disclosed on the company information page. The company's principal place of business is 7-11 Holywells Road, Ipswich IP3 0DL.
The Company extended its year end from 30 June 2023 to 31 December 2023 as part of the company restructuring plans. These financial statements present the activity of the company for the 18 month period ended 31 December 2023 which are not entirely comparable to the previous 12 months ended 30 June 2023.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is GBP.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in profit or loss except when deferred in other comprehensive income as qualifying cash flow hedges.

Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are presented in the Statement of income and retained earnings within 'finance income or costs'. All other foreign exchange gains and losses are presented in profit or loss within 'other operating income'.

Page 3

 


SHUTTLEWORTH MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
2.4

Pensions

Defined contribution pension plan

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Statement of financial position. The assets of the plan are held separately from the Company in independently administered funds.

 
2.5

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.

 
2.6

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

Page 4

 


SHUTTLEWORTH MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

2.Accounting policies (continued)

 
2.7

Stocks

Stocks are stated at the lower of cost and net realisable value, being the estimated selling price less costs to complete and sell. Cost is based on the cost of purchase on a first in, first out basis. Work in progress and finished goods include labour and attributable overheads.

At each reporting date, stocks are assessed for impairment. If stock is impaired, the carrying amount is reduced to its selling price less costs to complete and sell. The impairment loss is recognised immediately in profit or loss.

 
2.8

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial
assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans
to related parties and investments in ordinary shares.


3.


Employees

The average monthly number of employees, including directors, during the period was 1 (2022 - 7).


4.


Intangible assets






Intellectual Property
Computer software
Total

£
£
£





At 1 July 2022
7,500
2,125
9,625


Disposals
(7,500)
(2,125)
(9,625)



At 31 December 2023

-
-
-





At 1 July 2022
7,500
1,224
8,724


Charge for the period on owned assets
-
162
162


On disposals
(7,500)
(1,386)
(8,886)



At 31 December 2023

-
-
-



Net book value



At 31 December 2023
-
-
-



At 30 June 2022
-
901
901



Page 5

 


SHUTTLEWORTH MEDICAL LTD
 


 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 DECEMBER 2023

5.


Debtors

31 December
30 June
2023
2022
£
£


Trade debtors
-
468,811

Amounts owed by group undertakings
133,756
51,656

Other debtors
-
7,198

Prepayments and accrued income
-
32,434

133,756
560,099



6.


Creditors: Amounts falling due within one year

31 December
30 June
2023
2022
£
£

Bank loans
-
50,000

Trade creditors
-
89,860

Amounts owed to group undertakings
-
319,250

Corporation tax
-
15,609

Other taxation and social security
376
12,105

Other creditors
-
14,984

Accruals and deferred income
-
3,000

376
504,808



7.


Creditors: Amounts falling due after more than one year

31 December
30 June
2023
2022
£
£

Bank loans
-
150,000

-
150,000



8.


Commitments under operating leases

The Company had total commitments under non-cancellable operating leases of £nil (2022 - £128,000)  at the reporting date.

 
Page 6